HUTCHMED (China) Limited (HCM) — Financial statements
Income statement, balance sheet, and cash flow for HUTCHMED (China) Limited — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 550↓12.7% | 630↓24.8% | 838↑96.5% | 426↑19.7% | 356 | |
| Cost of Revenue | 337↓3.3% | 349↓9.3% | 384↑23.6% | 311↑20.5% | 258 | |
| Gross Profit | 213↓24.4% | 281↓38.0% | 454↑293.3% | 115↑17.8% | 98 | |
| Operating Expenses | ||||||
| R&D Expenses | 164↓23.1% | 213↓29.6% | 303↑13.3% | 268↑29.0% | 207 | |
| General & Administrative Expenses | 0.00↓100.0% | 64↓19.4% | 80↓13.4% | 92↑3.2% | 89 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 49↓8.9% | 53↑21.5% | 44↑16.1% | 38 | |
| SG&A Expenses | 103↓8.5% | 113↓15.2% | 133↓2.2% | 136↑7.1% | 127 | |
| Other Expenses | 0.00↑100.0% | -4 | 0.00↓100.0% | 119↑30.2% | 92 | |
| Operating Expenses | 267↓16.9% | 322↓26.2% | 436↓16.6% | 523↑22.7% | 426 | |
| Total Costs & Expenses | 605↓10.3% | 674↓17.8% | 820↓1.7% | 834↑21.9% | 684 | |
| Operating Results | ||||||
| Operating Income | -55↓25.2% | -44↓337.9% | 18↑104.5% | -410↓24.8% | -328 | |
| Depreciation & Amortization | 13↑8.1% | 12↑50.4% | 8↓5.3% | 9↑20.5% | 7 | |
| EBITDA | -41↓31.9% | -31↓218.0% | 27↑106.6% | -401↓92.9% | -208 | |
| EBIT | -55↓25.2% | -44↓337.9% | 18↑104.5% | -410↓90.5% | -215 | |
| Interest & Other Income | ||||||
| Net Interest Income | 47↑26.7% | 37↑5.1% | 35↑295.5% | 9↑502.9% | 1 | |
| Interest Income | 50↑24.8% | 40↑10.9% | 36↑276.5% | 10↑362.4% | 2 | |
| Interest Expense | 3↑0.0% | 3↑278.4% | 0.76↑16.4% | 0.65↑10.1% | 0.59 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 2 | 0.00 | |
| Other Income / Expenses | 577↑548.3% | 89↑2.1% | 87↑69.3% | 52↓70.3% | 173 | |
| Income Before Tax | 523↑1052.3% | 45↓57.0% | 106↑129.3% | -360↓131.9% | -155 | |
| Income Tax Expense | 64↑786.8% | 7↑59.5% | 5↑1693.3% | -0.28↓102.4% | 12 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 459↑1102.4% | 38↓62.2% | 101↑128.1% | -360↓115.7% | -167 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 458↑1114.2% | 38↓62.6% | 101↑127.9% | -361↓85.4% | -195 | |
| Bottom-Line Net Income | 458↑1114.2% | 38↓62.6% | 101↑127.9% | -361↓85.4% | -195 | |
| EPS (Basic) | 2.65↑1104.5% | 0.22↓63.3% | 0.60↑127.9% | -2.15↓72.0% | -1.25 | |
| EPS (Diluted) | 2.60↑1081.8% | 0.22↓63.3% | 0.60↑127.9% | -2.15↓72.0% | -1.25 | |
| Weighted Average Shares | 172↑0.3% | 171↑0.7% | 170↑0.3% | 169↑6.9% | 159 | |
| Weighted Average Diluted Shares | 175↑0.0% | 175↑0.4% | 174↑2.6% | 169↑6.9% | 159 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.